Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Temozolomide for Neuroendocrine Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
- Status
- COMPLETED
- Phase
- PHASE2
Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE3
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status
- Status
- COMPLETED
- Phase
- PHASE2
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
- Status
- COMPLETED
- Phase
- PHASE2
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE3
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
- Status
- TERMINATED
- Phase
- NA
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3